CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

Clustered regularly interspaced short palindromic repeat-associated protein Cas9 (CRISPR/Cas9) technology is at the forefront of cancer immunotherapy innovation, offering precise and personalized treatment strategies. In this review, we discuss CRISPR/Cas9’s ability to precisely edit the genome, its...

Full description

Bibliographic Details
Main Authors: Hyeseon Park, Yoo Kyung Kang, Gayong Shim
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmaceutics
Subjects:
CRISPR/Cas9
cancer immunotherapy
immune checkpoint
T-cell therapy
Online Access:https://www.mdpi.com/1999-4923/16/3/346

Similar Items

Similar Items